Broadcom Q2 revenue skyrockets 48% as AI semiconductor demand hits record highs
Broadcom (NASDAQ:AVGO) reported strong financial results for the second quarter of fiscal year 2026, underscored by exceptional growth in its semiconductor segment.
Broadcom (NASDAQ:AVGO) reported strong financial results for the second quarter of fiscal year 2026, underscored by exceptional growth in its semiconductor segment.
CrowdStrike Holdings (NASDAQ:CRWD) has reported its financial results for the first quarter of fiscal 2027, ended April 30, 2026, showcasing sustained growth and improved operational profitability.
Five Below (NASDAQ:FIVE) reported robust financial results for the first quarter of fiscal 2026, characterized by high double-digit growth in both top-line revenue and comparable store sales.
Crude oil prices extended gains on Wednesday, rising approximately 2% as market participants reacted to a significant escalation in Middle East hostilities and a breakdown in diplomatic communication between Tehran and Washington.
GitLab (NASDAQ:GTLB) has confirmed the layoff of approximately 350 employees, representing 14% of its workforce, as the company implements a restructuring plan designed to align its operations with the evolving demands of artificial intelligence.
Eli Lilly and Company (NYSE:LLY) has announced a significant research and licensing collaboration with Ascidian Therapeutics aimed at developing novel treatments for inherited kidney diseases.
Novo Nordisk (NYSE:NVO) has launched its oral Wegovy weight loss medication in the United Arab Emirates (UAE), marking the first international rollout of the drug outside the United States.
RTX (NYSE:RTX) announced today that its Raytheon business has been awarded a $515 million follow-on contract from the U.S. Navy to continue the production and integration of the SPY-6 family of radars.
Kura Oncology (NASDAQ:KURA) has released preliminary Phase 1a data showcasing the potential of its next-generation farnesyl transferase inhibitor (FTI), darlifarnib, as a foundational component of combination therapies for KRAS-mutant cancers.
Oshkosh Defense, a business unit of Oshkosh Corporation (NYSE:OSK), has been awarded new orders valued at $142 million for its Family of Medium Tactical Vehicles (FMTV) A2 platform.
GARANTA JÁ SEU GRAFA EDGE
Sign up free to unlock this feature
Vamos ativar um teste de 30 dias do Edge como presente de boas-vindas